TheWealthWeb

Tata India Pharma & Healthcare Fund - Reinvestment of Income Distribution cum capital withdrawal option Direct IDCW

Tata Mutual FundEquity Scheme - Sectoral/ ThematicDirect · IDCWRisk: Very High

NAV ₹38.4646 on 13 November 2026

AMFI name: TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option · Scheme code 135808

1 year
+6.85%
3 years, a year
+17.69%
5 years, a year
+15.02%
Since 18 Oct 2021, a year
+14.13%

IDCW option: returns are NAV changes and leave out payouts, so they understate what investors received. Risk ratios are not shown for payout options.

NAV performance, last year

Returns

To 13 November 2026. Up to 1 year: total change. 3 and 5 years: compound return a year.

PeriodThis fundNIFTY HEALTHCARE INDEX TRICategory median
1M+7.34%+8.67%+5.71%
6M+6.63%+12.84%+7.79%
1Y+6.85%+38.92%+4.11%
3Y+17.69%+28.05%+14.35%
5Y+15.02%-+12.25%

Benchmark: NIFTY HEALTHCARE INDEX TRI (total return index), measured over the same dates. The scheme document names BSE Healthcare TRI, which we do not hold, so this is the closest NSE index.

Category median: the middle return among Direct plans (Growth option) in AMFI's “Equity Scheme - Sectoral/ Thematic” category, up to 174 funds with clean data. Ranks are under “Rank among peers”.

Rank among peers

Direct plans, Growth option, in AMFI's “Equity Scheme - Sectoral/ Thematic” category. Each rank counts only the peers that have that figure.

Compare with Top Peers
3-Year Return Rank
-of 8
+17.69%
N/A
Q1
Q2
Q3
Q4
1-Year Return Rank
-of 8
+6.85%
N/A
Q1
Q2
Q3
Q4
Sharpe (Risk-Adjusted)
-of 8
-
N/A
Q1
Q2
Q3
Q4
Highest 3-year returns in the categoryDirect plans · Growth option
RankScheme Name3Y Return1Y ReturnSharpeDirect TERAUM
#1
Nippon India Mutual Fund
+46.52%+60.64%1.071.06%₹1,100 Cr
#2
HDFC Mutual Fund
+33.64%+20.34%1.070.89%₹11,128 Cr
#3
HDFC Mutual Fund
+31.28%+31.60%1.761.03%₹3,128 Cr
#4
SBI Mutual Fund
+25.42%+26.07%1.470.76%₹5,565 Cr
#5
HDFC Mutual Fund
+24.77%+10.10%1.091.10%₹1,997 Cr
#6
Mirae Asset Mutual Fund
+24.42%+27.89%1.28-₹3,458 Cr
#7
UTI Mutual Fund
+23.89%+22.00%1.311.35%₹1,399 Cr
#8
ICICI Prudential Mutual Fund
+22.73%+10.29%0.952.08%₹3,926 Cr
#-
Tata India Pharma & Healthcare Fund - Reinvestment of Income Distribution cum capital withdrawal optionCurrent Fund
Tata Mutual Fund
+17.69%+6.85%-1.07%₹1,534 Cr

Costs and fund facts

Expense ratio (stated maximum)
Direct 1.07% · Regular 2.37%
Exit load
0.25% of NAV if redeemed /switched out before 30 days from the date of allotment.
Fund size (all plans)
₹1,534 CrAverage, quarter to September 2026
Benchmark
BSE Healthcare TRICompared here with NIFTY HEALTHCARE INDEX TRI
Allotment date
28 December 2015Scheme document
Type
An open ended equity scheme investing in Pharma and Healthcare Services Sector.
AMFI scheme code
135808

Fund manager

  • Rajat Srivastavasince 16-Sep-2024

How each manager has done since taking over: fund manager scorecard.

Investment objective

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

From the scheme summary document filed with AMFI.

SIP calculator

A monthly SIP replayed on this fund's actual daily NAVs: what it would be worth today.

IDCW option: values use the NAV only and leave out the payouts, so they understate what an investor received. The Growth option of this fund shows the full return.

Monthly SIP Amount₹10,000
Investment Horizon5 Years
Simulating monthly 1st from 15 Nov 2021 to 13 Nov 2026
Total Invested61 mos
₹6,10,000
Units: 23,923.657
Current Portfolio Value
₹9,20,214
At latest recorded NAV
Total Profit
+₹3,10,214
+50.9% absolute return
SIP XIRR
16.48%
Annualised, money-weighted
Wealth CompositionProfit is 51% of total invested capital
Invested: ₹6,10,000Profit Generated: ₹3,10,214
Same SIP in the benchmark (NIFTY HEALTHCARE INDEX TRI)Same dates & amounts
Scheme SIP Valuation
₹9,20,214
16.5% XIRR
Benchmark SIP Valuation
₹5,56,767
25.8% XIRR
Fund minus benchmark
+₹3,63,447
Over 61 monthly installments
SIP instalments are bought on the first NAV date of each month; values use the latest NAV we hold. Past returns are not a guide to future returns.

About this fund

Tata India Pharma & Healthcare Fund - Reinvestment of Income Distribution cum capital withdrawal option Direct IDCW is a mutual fund scheme from Tata Mutual Fund, listed by AMFI under “Equity Scheme - Sectoral/ Thematic”. This page covers the Direct plan with the IDCW option. Its NAV was ₹38.4646 on 13 November 2026. Its NAV changed by 6.85% over 1 year, 17.69% a year over 3 years and 15.02% a year over 5 years. These figures leave out IDCW payouts, so they understate what investors received. Its benchmark, NIFTY HEALTHCARE INDEX TRI, returned 28.05% a year over 3 years. The fund house rates its risk as “Very High” on the SEBI riskometer. Its average assets under management were ₹1,534 Cr across all plans for the quarter ending September 2026, as reported to AMFI. Its scheme summary document states a maximum expense ratio (TER) of 1.07% a year for the Direct plan. Managed by Rajat Srivastava. Its scheme summary document gives the allotment date as 28 December 2015.

Figures are calculated from AMFI NAVs and index data, not taken from fund factsheets. Methodology. Past performance is not a guide to future returns.

Plans and options of this fund (1)

PlanOptionISINAMFI codeNAV
DirectGrowthINF277K019A3135810₹39.7613 Nov 2026